Filing Details
- Accession Number:
- 0001232524-10-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-01 17:14:36
- Reporting Period:
- 2010-08-31
- Filing Date:
- 2010-09-01
- Accepted Time:
- 2010-09-01 17:14:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Inc | JAZZ | Pharmaceutical Preparations (2834) | 050563787 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1193210 | C Bruce Cozadd | C/O Jazz Pharmaceuticals 3180 Porter Drive Palo Alto CA 94304 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-08-31 | 10,000 | $8.60 | 280,181 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.50 to $8.64, inclusive.
- The reporting person undertakes to provide to Jazz Pharmaceuticals, Inc., any security holder of Jazz Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
